| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +42.6K | 36.2% | $10.22 | +$435K |
| Sells | 1 | -75K | 63.8% | $14.53 | -$1.09M |
| Net | +3 | -32.4K | -27.6% | -$654K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thomas S. Mchugh | Chief Financial Officer | $2.08M | +$105K | +5.33% | Dec 13, 2024 |
| Eric J. Ende | Director | $1.82M | Jul 30, 2024 | ||
| Mark Anthony McCamish | Director | $1.77M | -$1.09M | -38.1% | Jul 30, 2024 |
| Gregory J. Divis | Chief Executive Officer, Director | $1.66M | +$99.7K | +6.4% | Dec 6, 2024 |
| Peter J. Thornton | Director | $958K | Jul 30, 2024 | ||
| Geoffrey Michael Glass | Director | $852K | +$200K | +30.6% | Dec 10, 2024 |
| Linda Palczuk | Director | $677K | +$30.6K | +4.73% | Dec 17, 2024 |
| Naseem Amin | Director | $112K | Jul 30, 2024 | ||
| Jerad G. Seurer | Gen. Counsel & Corp. Secretary | $89.6K | Apr 30, 2024 | ||
| Douglas J. Williamson | Chief Medical Officer | Feb 14, 2022 | |||
| Richard J. Kim | Chief Commercial Officer | Feb 20, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|